Case report of recurrent focal segmental glomerulosclerosis (FSGS) after kidney transplantation successfully managed with a tailored immunosuppressive regimen including low-dose tacrolimus, mycophenolate mofetil, and rituximab. Early recognition through laboratory monitoring and biopsy confirmation allowed timely intervention, resulting in remission of proteinuria and stabilization of renal function. This case highlights the value of individualized immunosuppressive strategies and emerging therapies in optimizing post-transplant FSGS outcomes.Click-Here-(Apply Form).com
Call for Co-AuthorsWe are pleased to announce an open call for:
6 Co-authorship slots on our upcoming medical case report.
• Prior research or publication experience is not required, we welcome new authors.
• Open to medical students (undergraduate and postgraduate), residents, and MDs.
• This is an excellent opportunity to gain authorship experience and contribute to a published work.
Deadline: September 15, 2025, at 11:59 PMFill out the form at the link above.
Slots are limited please apply promptly.